Practical problems with aerosol therapy in COPD

Respiratory Care

Volumn 51, Issue 2, 2006, Pages 158-172

  Rau, Joseph L ^a,b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Breath actuated pressurized inhalers; Chronic obstructive pulmonary disease; Dry powder inhaler; Holding chamber; Inhaler; Metered dose inhaler; Nebulizer; Spacer

Indexed keywords

BECLOMETASONE; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; FORMOTEROL FUMARATE; HYDROCORTISONE; IPRATROPIUM BROMIDE; LEVALBUTEROL; MOMETASONE; PIRBUTEROL; PIRBUTEROL ACETATE; PREDNISONE; SALBUTAMOL; SALMETEROL; SALMETEROL XINAFOATE; TERBUTALINE; TIOTROPIUM BROMIDE; TRIAMCINOLONE; UNCLASSIFIED DRUG; ZANAMIVIR;

AEROSOL; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; BREATH HOLDING; CAREGIVER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONFUSION; DRUG BIOAVAILABILITY; DRY POWDER; DYSPRAXIA; ELECTRICITY; ERROR; HAND GRIP; HEALTH CARE PERSONNEL; HUMAN; HUMIDITY; KNOWLEDGE; LEARNING; MEDICAL PERSONNEL; MENTAL HEALTH; METERED DOSE INHALER; MODEL; NEBULIZER; PATIENT EDUCATION; PERFORMANCE; POWDER INHALER; PREDICTOR VARIABLE; REVIEW; CLINICAL COMPETENCE; DRUG SELF ADMINISTRATION; EQUIPMENT DESIGN; INHALATION SPACER; INHALATIONAL DRUG ADMINISTRATION; MEDICATION ERROR;

ADMINISTRATION, INHALATION; AEROSOLS; CLINICAL COMPETENCE; EQUIPMENT DESIGN; HUMANS; INHALATION SPACERS; MEDICATION ERRORS; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF ADMINISTRATION;

EID: 33748135238     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Dulfano MJ, Glass P. The bronchodilator effects of terbutaline: route of administration and patterns of response. Ann Allergy 1976;37(5):357-366.
2. Grimwood K, Johnson-Barrett JJ, Taylor B. Salbutamol: tablets, inhalational powder, or nebuliser? Br Med J (Clin Res Ed) 1981;282(6258):105- 106.
3. Koninck JC, Magro P, Khanjari F, Lemarié E, Diot P. HFA inhalers. Pediatr Pulmonol Suppl 2004;26:23-25.
4. Ross DL, Gabrio BJ. Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system. J Aerosol Med 1999;12(3):151-160.
5. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163(5):1256-1276.
6. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines. American College of Chest Physicians /American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335-371.
7. Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 2001;5(26):1-149.
8. Wright J, Brocklebank D, Ram F. Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD). Qual Saf Health Care 2002;11(4):376-382.
9. van der Palen J, Klein JJ, van Herwaarden CLA, Zielhuis GA, Seydel ER. Multiple inhalers confuse asthma patients. Eur Respir J 1999;14(5):1034-1037.
10. Seeto L, Lim S. Asthma and COPD. Inhalation therapy - clarity or confusion? Aust Fam Physician 2001;30(6):557-561.
11. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002;19(2):246-251.
12. Corden ZM, Bosley CM, Rees PJ, Cochrane GM. Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest 1997;112(5):1278-1282.
13. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005;50(10):1360-1374; discussion 1374-1375.
14. Freedman T. Medihaler therapy for bronchial asthma: a new type of aerosol therapy. Postgrad Med 1956;20(6):667-673.
15. Thiel CG. From Susie's question to CFC free: an inventor's perspective on forty years of MDI development and regulation. In: Dalby RN, Byron PR, Farr SJ, editors. Respiratory drug delivery, 5th ed. Buffalo Grove, IL: Interpharm Press;1996:115-123.
16. Saunders KB. Misuse of inhaled bronchodilator agents. Br Med J 1965;5441:1037-1038.
17. Coady TJ, Stewart CJ, Davies HJ. Synchronization of bronchodilator release. Practitioner 1976;217(1248):273-275.
18. Orehek J, Gayrard P, Grimaud C, Charpin J. Patient error in use of bronchodilator metered aerosols. Br Med J 1976;1(6001):76.
19. Paterson IC, Crompton GK. Use of pressurised aerosols by asthmatic patients. Br Med J 1976;1(6001):76-77.
20. Crompton GK. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis Suppl 1982;119:101-104.
21. Thompson J, Irvine T, Grathwohl K, Roth B. Misuse of metered-dose inhalers in hospitalized patients. Chest 1994;105(3):715-717.
22. McFadden ER Jr. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J Allergy Clin Immunol 1995;96(2):278-283.
23. Newman SP, Woodman G, Clarke SW, Sackner MA. Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract. Chest 1986;89(4):551-556.
24. Ogren RA, Baldwin JL, Simon RA. How patients determine when to replace their metered-dose inhalers. Ann Allergy Asthma Immunol 1995;75(6 Pt 1):485-489.
25. Rubin BK, Durotoye L. How do patients determine that their metered-dose inhaler is empty? Chest 2004;126(4):1134-1137.
26. Schultz RK. Drug delivery characteristics of metered-dose inhalers. J Allergy Clin Immunol 1995;96(2):284-287.
27. Interiano B, Guntupalli KK. Metered-dose inhalers. Do health care providers know what to teach? Arch Intern Med 1993;153(1):81-85.
28. Guidry GG, Brown WD, Stogner SW, George RB. Incorrect use of metered dose inhalers by medical personnel. Chest 1992;101(1):31-33.
29. Jones JS, Holstege CP, Riekse R, White L, Bergquist T. Metered-dose inhalers: do emergency health care providers know what to teach? Ann Emerg Med 1995;26(3):308-311.
30. Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest 1993;104(6):1737-1742.
31. Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med 1996;156(9):984-988.
32. Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J 2002;78(915):37-39.
33. Allen SC, Prior A. What determines whether an elderly patient can use a metered dose inhaler correctly? Br J Dis Chest 1986;80(1):45-49.
34. De Blaquiere P, Christensen DB, Carter WB, Martin TR. Use and misuse of metered-dose inhalers by patients with chronic lung disease: a controlled, randomized trial of two instruction methods. Am Rev Respir Dis 1989;140(4):910-916.
35. Goodman DE, Israel E, Rosenberg M, Johnston R, Weiss ST, Drazen JM. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med 1994;150(5 Pt 1):1256-1261.
36. Newman SP, Morén F, Pavia D, Little F, Clarke SW. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis 1981;124(3):317-320.
37. Dolovich M, Ruffin R, Corr D, Newhouse MT. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 1983;84(1):36-41.
38. Wildhaber JH, Devadason SG, Eber E, Hayden MJ, Everard ML, Summers QA, LeSouëf PN. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax 1996;51(10):985-988.
39. O'Callaghan C, Lynch J, Cant M, Robertson C. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax 1993;48(6):603-606.
40. Clark DJ, Lipworth BJ. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax 1996;51(10):981-984.
41. Wildhaber JH, Devadason SG, Hayden MJ, James R, Dufty AP, Fox RA, et al. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur Respir J 1996;9(9):1943-1946.
42. Piérart F, Wildhaber JH, Vrancken I, Devadason SG, Le Souëf PN. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999;13(3):673-678.
43. Kenyon CJ, Thorsson L, Borgström L, Newman SP. The effects of static charge in spacer devices on glucocorticosteroid aerosol disposition in asthmatic patients. Eur Respir J 1998;11:606-610.
44. Mitchell JP, Rau JL, Coppolo D, Nagel MW, Avvakoumova VI, Doyle CC, Wiersema KJ. Is the use of electrostatic charge-dissipative materials effective as a means of improving aerosol delivery by valved holding chamber (VHC) to the poorly coordinated patient? (abstract) Proceedings of the American Thoracic Society 2005;Vol 2:A377.
45. Rau JL, Restrepo RD, Deshpande V. Inhalation of single vs multiple metered-dose bronchodilator actuations from reservoir devices: an in vitro study. Chest 1996;109(4):969-974.
46. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994;105(1):111-116.
47. Bell JH, Hartley PS, Cox JS. Dry powder aerosols. I. A new powder inhalation device. J Pharm Sci 1971;60(10):1559-1564.
48. Melani AS, Zanchetta D, Barbato N, Sestini P, Cinti C, Canessa PA, et al. Associazione Italiana Pneumologi Ospedalieri Educational Group. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol 2004;93(5):439-446.
49. van Beerendonk I, Mesters I, Mudde AN, Tan TD. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma 1998;35(3):273-279.
50. van der Palen J, Klein JJ, Kerkhoff AHM, van Herwaarden CLA. Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease. Thorax 1995;50(11):1183-1187.
51. Oliver S, Rees PJ. Inhaler use in chronic obstructive pulmonary disease. Int J Clin Pract 1997;51(7):443-445.
52. Diggory P, Fernandez C, Humphrey A, Jones V, Murphy M. Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomized controlled trial. BMJ 2001;322(7286):577-579.
53. Maggi L, Bruni R, Conte U. Influence of the moisture on the performance of a new dry powder inhaler. Int J Pharm 1999;177(1):83-91.
54. Meakin BJ, Cainey J, Woodcock PM. Effect of exposure to humidity on terbutaline delivery from turbuhaler dry powder inhalation devices (letter). Eur Respir J 1993;6(5):760-761.
55. Fuller R. The Diskus: a new multi-dose powder device - efficacy and comparison with Turbuhaler. J Aerosol Med 1995;8(Suppl 2):S11-S17.
56. Tobyn M, Staniforth JN, Morton D, Harmer Q, Newton ME. Active and intelligent inhaler device development. Int J Pharm 2004;277(1-2):31-37.
57. Borgström L. On the use of dry powder inhalers in situations perceived as constrained. J Aerosol Med 2001;14(3):281-287.
58. Burnell PKP, Small T, Doig S, Johal B, Jenkins R, Gibson GJ. Ex-vivo product performance of Diskus and Turbuhaler inhalers using inhalation profiles from patients with severe chronic obstructive pulmonary disease. Respir Med 2001;95(5):324-330.
59. Pedersen S, Hansen OR, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990;65(3):308-310.
60. Nielsen KG, Auk IL, Bojsen K, Ifversen M, Klug B, Bisgaard H. Clinical effect of Diskus dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children. Eur Respir J 1998;11(2):350-354.
61. Dewar MH, Jamieson A, McLean A, Crompton GK. Peak inspiratory flow through Turbuhaler in chronic obstructive airways disease. Respir Med 1999;93(5):342-344.
62. Broeders ME, Molema J, Hop WC, Vermue NA, Folgering HT. The course of inhalation profiles during an exacerbation of obstructive lung disease. Respir Med 2004;98(12):1173-1179.
63. Chodosh S, Flanders JS, Kesten S, Serby CW, Hochrainer D, Witek TJ Jr. Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity. J Aerosol Med 2001;14(3):309-315.
64. Dahl R, Backer V, Ollgaard B, Gerken F, Kesten S. Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction. Respir Med 2003;97(10):1126-1133.
65. Nelson H, Kemp JP, Bieler S, Vaughan LM, Hill MR. Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma. Chest 1999;115(2):329-335.
66. Hess D, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest 1996;110(2):498-505.
67. Newman SP, Clarke SW. Nebulisers: uses and abuses (editorial). Arch Dis Child 1986;61(5):424-425.
68. Thorsson L, Geller D. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide. Respir Med 2005;99(7):836-849.
69. Balzano G, Battiloro R, Biraghi M, Stefanelli F, Fuschillo S, Gaudiosi C, De Angelis E. Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. J Aerosol Med 2000;13(1):25-33.
70. Coady TJ, Davies HJ, Barnes P. Evaluation of a breath actuated pressurized aerosol. Clin Allergy 1976;6(1):1-6.
71. Fergusson RJ, Lenney J, McHardy GJR, Crompton GK. The use of a new beath-actuated inhaler by patients with severe airflow obstruction. Eur Respir J 1991;4(2):172-174.
72. Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest 1993;104(5):1332-1337.
73. Newman SP, Weisz AWB, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler technique. Thorax 1991;46(10):712-716.
74. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med 2000;94(5):496-500.
75. Kamin WES, Genz T, Roeder S, Scheuch G, Trammer T, Juenemann R, Cloes RM. Mass output and particle size distribution of glucocorticosteroids emitted from different inhalation devices depending on various inspiratory parameters. J Aerosol Med 2002;15(1):65-73.
76. Fink JB. Inhalers in asthma management: is demonstration the key to compliance? (editorial) Respir Care 2005;50(5):598-600.
77. Song WS, Mullon J, Regan NA, Roth BJ. Instruction of hospitalized patients by respiratory therapists on metered-dose inhaler use leads to decrease in patient errors. Respir Care 2005;50(8):1040-1045.
78. Serra-Batlles J, Plaza V, Badiola C, Morejón E. Inhalation Devices Study Group. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med 2002;15(1):59-64.
79. Moore AC, Stone S. Meeting the needs of patients with COPD: patients' preference for the Diskus inhaler compared with the Handi-Haler. Int J Clin Pract 2004;58(5):444-450.
80. Ganderton D. Targeted delivery of inhaled drugs: current challenges and future goals. J Aerosol Med 1999;12 Suppl 1:S3-S8.
81. Dolovich M. New propellant-free technologies under investigation. J Aerosol Med 1999;12 Suppl 1:S9-S17.